The extreme presentation of hyperreactive malaria is hyperreactive malarial
splenomegaly syndrome (HMS). Some patients present with a less pronounced
syndrome. To investigate whether the degree of splenomegaly correlates with
the degree of immune stimulation, whether prophylaxis or recent treatment
play a role, and whether short therapy alone is effective, we examined retr
ospectively the medical records of expatriates with exposure to P. falcipar
um who attended our outpatient department from 1986 to 1997, particularly s
ubacute symptoms or signs, strongly elevated malarial antibodies and elevat
ed total serum IgM. We analysed duration of stay, prophlyaxis intake, splee
n size, serum IgM levels and response to antimalarial treatment. Serum IgM
levels were significantly higher in patients with larger splenomegaly. The
use of chloroquine alone as treatment for presumptive or proved malaria att
acks was correlated with larger spleen size. Short adequate antimalarial th
erapy resulted in marked improvement or complete recovery In nine patients
the hyperreactive response reappeared after re-exposure, in four of them tw
ice. We conclude that patients with subacute symptoms but without gross spl
enomegaly may have very high levels of IgM and malarial antibodies, and rel
apse on re-exposure, suggesting the existence of a variant of the hyperreac
tive malarial splenomegaly syndrome without gross splenomegaly.